Menu

Blog

Archive for the ‘genetics’ category: Page 149

Feb 28, 2023

Social deficits and seizures in autism genetic subtype tied to overexcited brain circuits

Posted by in categories: biotech/medical, genetics, neuroscience

Northwestern Medicine scientists have identified the cause of a genetic subtype of autism and schizophrenia that results in social deficits and seizures in mice and humans.

Scientists have discovered a key feature of this subtype is a duplicated gene that results in overactive or overexcited brain circuits. The subtype is called 16p11.2 duplication syndrome.

“We found that mice with the same found in humans are more likely to have and also have ,” said lead author Marc Forrest, research assistant professor of neuroscience at Northwestern University Feinberg School of Medicine.

Feb 28, 2023

Precise multimodal optical control of neural ensemble activity

Posted by in categories: genetics, neuroscience

The authors present a new approach to create and edit custom spatiotemporal neural activity patterns in awake, behaving animals with extremely high spatial and temporal precision. They present novel opsins optimized for multiphoton optogenetics.

Feb 27, 2023

How the influenza virus achieves efficient viral RNA replication

Posted by in categories: biotech/medical, genetics, health

New insights on how subunits of the influenza virus polymerase co-evolve to ensure efficient viral RNA replication are provided by a study published October 3 in the open-access journal PLOS Pathogens by Nadia Naffakh of the Institut Pasteur, and colleagues. As the authors note, the findings could lead to novel strategies for antiviral drug development.

Because of their yearly recurrence and the occasional emergence of pandemics, influenza viruses represent a worldwide major public health threat. Enhancing fundamental knowledge about the influenza RNA–, which is an enzyme that consists of three subunits (i.e., a heterotrimer) and ensures transcription and of the viral genome, is essential to reach the goal of better prevention and treatment of disease.

In the new study, Naffakh and colleagues gained new insights into viral polymerase function. They showed that the polymerase subunits co-evolve to ensure not only optimal inter-subunit cooperation within the heterotrimer, but also proper levels dimerization—the process by which pairs of heterotrimers attach together—which appears to be essential for efficient viral RNA replication. The findings point to polymerase dimerization as a feature that can restrict genetic reassortment, a major evolutionary mechanism in which swap gene segments, and could become an attractive target for antiviral drug development.

Feb 27, 2023

VKORC1 single nucleotide polymorphisms in rodents in Spain

Posted by in categories: augmented reality, biotech/medical, food, genetics, health

Rodents are considered one of the animal pests with the greatest impact on agricultural production and public health, especially the brown or Norway rat (Rattus norvegicus), the black or roof rat (Rattus rattus) and the house mouse (Mus musculus). Its control is an increasing problem worldwide. The intensification of agricultural production methods as well as the increase in merchandise transport to sustain growing populations is leading to an increase in waste production causing the growth of these rodent populations. The estimated losses in crop production caused by rodents range from between 5% and 90% (Stenseth et al., 2003) and this can cause problems in food security during harvesting (Belmain et al., 2015). Other negative impacts result from some rodent species living very close to human environments that can have a direct influence not only on human health through potential transmission of gastroenteric diseases and zoonosis to householders but also on domestic livestock. Therefore, rodent pest control is crucial and nowadays, the only effective control method available is the use of anticoagulant rodenticides (ARs).

ARs are so named because they interfere with the blood coagulation processes. The processes of activating various coagulation factors depends on the amount of vitamin K in its reduced form that exists in the organism. ARs inhibit the enzyme vitamin K 2,3-epoxide reductase (VKORC1) that is responsible for reducing vitamin K and maintaining the balance between its oxidized and reduced forms. The inhibition of VKORC1 prevents the activation of the coagulation factors resulting in animal death by internal bleeding. However, the intensive use of ARs can cause rodents to lose their susceptibility and become resistant to them. Genetic resistances to ARs are mainly associated with mutations or single nucleotide polymorphisms (SNPs) in the gene that codes for VKORC1 (vkorc1), causing amino acid substitutions in the VKORC1 protein ( Pelz et al., 2005 ). There are studies on this topic in several countries of central and northern Europe detecting rodent populations resistant to AR. Currently, there are at least 13 mutations mainly located in the exon 3 of the vkorc1 gene described in various countries of the European Union that confer resistance to specific ARs ( Berny et al., 2014 ; Goulois et al., 2017 ). In Eastern and Southern European countries, the information on the incidence of resistances to rodenticides is scarce, and it is becoming increasingly important to generate information on this subject ( Berny et al., 2014). In Spain, a mice population at the coastal countryside showing an adaptive introgression between house mouse and Algerian mouse that confers anticoagulant resistance has been described ( Song et al., 2011 ). While recently, four VKORC1 mutations in black rat were found in Toledo, Segovia and Zaragoza ( Goulois et al., 2016 ; Damin-Pernik et al., 2022 ). Any increase in resistant in rodent populations would lead to pest control issues that may causing serious agricultural, farming and public health problems.

Scientific advances have revolutionized the study of anticoagulant resistances in terms of understanding their genetic basis, physiological mechanisms and geographical distribution. The techniques based on the extraction and partial sequencing of genomic DNA allow a fast and precise monitoring of possible genetic resistances. Most of these tests involve laboratory studies using live rodents or blood samples taken from animals in the field. However, the improvement of DNA extraction techniques now allows the analysis of faecal samples (stool), increasing the number of samples that can be taken without the need for sampling by trapping or the management of dead animals (Meerburg et al., 2014). The importance of initial detection of genetic resistances due to mutations is crucial. The hypothesis of work, presenting it as a null hypothesis, is that there will be no rodent mutations in the vkorc1 gene in Spain.

Feb 26, 2023

New Hope for Treatment of Rare Metabolic Brain Disease

Posted by in categories: biotech/medical, genetics, neuroscience

X-ALD is the most prevalent of the approximately 50 rare diseases that affect the white matter of the brain, referred to as leukodystrophies. The genetic damage in X-ALD is due to a defect in the X chromosome. Men who are affected by X-ALD experience a progressive deterioration of their mobility, balance, and sensory abilities, leading to issues such as incontinence and sexual dysfunction.

Although X-ALD is inherited through the X chromosome, female carriers can also experience symptoms of the disease. Approximately 30% of male children and 60% of adult men develop encephalitis, which is a fatal form of the disease that leads to death within two to three years. X-ALD affects roughly one in every 20,000 births globally.

Now, for the first time, scientists from all relevant leukodystrophy centers in Europe and the US have jointly succeeded in obtaining controlled trial data for X-linked adrenoleukodystrophy. Of the 116 patients, 77 received the drug leriglitazone and 39 a placebo. The drug had already shown in preclinical studies that it can prevent neurodegeneration and offer protection against the life-threatening inflammation of the brain.

Feb 26, 2023

Extinct-in-the-wild species in conservation limbo

Posted by in categories: existential risks, genetics

For species classified as “extinct in the wild”, the zoos and botanical gardens where their fates hang by a thread are as often anterooms to oblivion as gateways to recovery, new research has shown.

Re-wilding what are often single-digit populations faces the same challenges that pushed these to the cusp of in the first place, including a lack of genetic diversity. But without , experts say, chances of these species surviving would be even smaller.

Since 1950, nearly 100 animal and plant species vanquished from nature by hunting, pollution, deforestation, invasive lifeforms and other drivers of extinction have been put into by scientists and conservationists, according to the findings.

Feb 26, 2023

How An Early Warning Radar Could Prevent Future Pandemics

Posted by in categories: biotech/medical, genetics, robotics/AI

On December 18, 2019, Wuhan Central Hospital admitted a patient with symptoms common for the winter flu season: a 65-year-old man with fever and pneumonia. AI Fen, director of the emergency department, oversaw a typical treatment plan, including antibiotics and anti-influenza drugs.

Six days later, the patient was still sick, and AI was puzzled, according to news reports and a detailed reconstruction of this period by evolutionary biologist Michael Worobey. The respiratory department decided to try to identify the guilty pathogen by reading its genetic code, a process called sequencing. They rinsed part of the patient’s lungs with saline, collected the liquid, and sent the sample to a biotech company. On December 27, the hospital got the results: The man had contracted a new coronavirus closely related to the one that caused the SARS outbreak that began 17 years before.

Feb 26, 2023

Epigenetic Test #4: What’s My Biological Age?

Posted by in categories: biotech/medical, genetics, life extension

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.

Continue reading “Epigenetic Test #4: What’s My Biological Age?” »

Feb 25, 2023

A new epigenetic brain defense against recurrence of opioid use

Posted by in categories: biotech/medical, genetics, neuroscience

Substance use disorder (SUD) is an extremely difficult disorder to overcome, and many individuals with SUD return to regular use after repeated attempts to quit.

A return to regular can be caused by the body’s physical dependence on the drug as well as experiences associated with prior drug use. Exactly how these drug associations are formed in the brain and how they trigger a return to drug use remain unclear.

“Individuals make long-lasting associations between the euphoric experience of the drug and the people, places and things associated with drug use,” said Christopher Cowan, Ph.D. professor in the Department of Neuroscience at the Medical University of South Carolina (MUSC) and member of the Brain and Behavior Research Foundation Scientific Council.

Feb 25, 2023

How scientists made this rat the oldest living lab rat — E5 rejuvenation?

Posted by in categories: biotech/medical, genetics, life extension, neuroscience

Talking about E5.


Rats are also useful for aging research and for cooking ratatouille. But in all seriousness, take a look at this recent headline article — “We have the oldest living female Sprague Dawley rat,” said Dr Harold Katcher, a former biology professor at the University of Maryland, now chief scientific officer at Yuvan Research, a California-based startup.

Continue reading “How scientists made this rat the oldest living lab rat — E5 rejuvenation?” »